ARCHIVES

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

Communication Is Key To Clinical Trial Enrollment

June 30, 2006

DD Should Transfer Part of Breast Cancer $$ To NIH r Peer Distribution, Broder Says

December 4, 1992

In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes

April 7, 1978

In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte

March 8, 1991

Program Announcement.

July 4, 2003